Do human extraintestinal escherichia coli infections resistant to expanded-spectrum cephalosporins originate from food-producing animals? A systematic review

Clinical Infectious Diseases

Volumn 60, Issue 3, 2015, Pages 439-452

  Lazarus, Benjamin ^a   Paterson, David L ^a   Mollinger, Joanne L ^b   Rogers, Benjamin A ^a,c  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b DEPARTMENT OF AGRICULTURE AND FISHERIES   (Australia)

^c SOUTHERN HEALTH   (Australia)

Author keywords

E. coli; ESBL; poultry; ST131; urinary tract; zoonosis

Indexed keywords

CEPHALOSPORIN DERIVATIVE;

BACTERIAL TRANSMISSION; CHICKEN MEAT; ENTEROPATHOGENIC ESCHERICHIA COLI; ENTEROPATHOGENIC ESCHERICHIA COLI INFECTION; ESCHERICHIA COLI; EXPANDED SPECTRUM CEPHALOSPORIN RESISTANT ESCHERICHIA COLI; EXPANDED SPECTRUM CEPHALOSPORIN RESISTANT ESCHERICHIA COLI INFECTION; FOOD INDUSTRY; FOOD ORGANISM; FOOD PRODUCING ANIMAL; HUMAN; KLEBSIELLA PNEUMONIAE; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; NETHERLANDS; NONHUMAN; POULTRY; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; REVIEW; SYSTEMATIC REVIEW; URINARY TRACT INFECTION; WHOLE BACTERIUM TRANSMISSION; ZOOGEOGRAPHY; ANIMAL; ANTIBIOTIC RESISTANCE; DRUG EFFECTS; ESCHERICHIA COLI INFECTIONS; GENETICS; LIVESTOCK; MICROBIOLOGY; MULTIDRUG RESISTANCE; TRANSMISSION; ZOONOSIS;

ANIMALS; CEPHALOSPORIN RESISTANCE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; LIVESTOCK; POULTRY; ZOONOSES;

EID: 84922464366     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciu785     Document Type: Review

References (73)

1. Pitout JD. Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 2010; 70: 313-33
2. Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-Analysis. J Antimicrob Chemother 2007; 60: 913-20
3. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States. Available at: http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-Threats-2013-508.pdf. Accessed 10 May 2014
4. Shooter RA, Cooke EM, Rousseau SA, Breaden AL. Animal sources of common serotypes of Escherichia coli in the food of hospital patients. Possible significance in urinary-Tract infections. Lancet 1970; 2: 226-8
5. Smith HW. Transfer of antibiotic resistance from animal and human strains of Escherichia coli to resident E. coli in the alimentary tract of man. Lancet 1969; 1: 1174-6
6. Vieira AR, Collignon P, Aarestrup FM, et al. Association between antimicrobial resistance in Escherichia coli isolates from food animals and blood stream isolates from humans in Europe: an ecological study. Foodborne Pathog Dis 2011; 8: 1295-301
7. Aarestrup FM, Wegener HC, Collignon P. Resistance in bacteria of the food chain: epidemiology and control strategies. Expert Rev Anti Infect Ther 2008; 6: 733-50
8. Cavaco LM, Abatih E, Aarestrup FM, Guardabassi L. Selection and persistence of CTX-M-producing Escherichia coli in the intestinal flora of pigs treated with amoxicillin, ceftiofur, or cefquinome. Antimicrob Agents Chemother 2008; 52: 3612-6
9. Shiraki Y, Shibata N, Doi Y, Arakawa Y. Escherichia coli producing CTX-M-2 beta-lactamase in cattle, Japan. Emerg Infect Dis 2004; 10: 69-75
10. Smet A, Martel A, Persoons D, et al. Broad-spectrum beta-lactamases among Enterobacteriaceae of animal origin: molecular aspects, mobility and impact on public health. FEMS Microbiol Rev 2009; 34: 295-316
11. World Health Organization. The evolving threat of antimicrobial resistance: options for action. Available at: http://www.who.int/patientsafety/implementation/amr/publication/en/. Accessed 20 November 2013
12. Ewers C, Bethe A, Semmler T, Guenther S, Wieler LH. Extended-spectrum beta-lactamase-producing and AmpC-producing Escherichia coli from livestock and companion animals, and their putative impact on public health: a global perspective. Clin Microbiol Infect 2012; 18: 646-55
13. Ishii Y. ESBL producing organisms [in Japanese]. Nihon Rinsho 2012; 70: 256-61
14. Randall L, Wu G, Phillips N, et al. Virulence genes in blaCTX-M Escherichia coli isolates from chickens and humans. Res Vet Sci 2012; 93: 23-7
15. Leverstein-van Hall MA, Dierikx CM, Cohen Stuart J, et al. Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strains. Clin Microbiol Infect 2011; 17: 873-80
16. Vinue L, Saenz Y, Martinez S, et al. Prevalence and diversity of extended-spectrum beta-lactamases in faecal Escherichia coli isolates from healthy humans in Spain. Clin Microbiol Infect 2009; 15: 954-7
17. Woerther PL, Burdet C, Chachaty E, Andremont A. Trends in human fecal carriage of extended-spectrum beta-lactamases in the community: toward the globalization of CTX-M. Clin Microbiol Rev 2013; 26: 744-58
18. Liebana E, Carattoli A, Coque TM, et al. Public health risks of enterobacterial isolates producing extended-spectrum beta-lactamases or AmpC beta-lactamases in food and food-producing animals: an EU perspective of epidemiology, analytical methods, risk factors, and control options. Clin Infect Dis 2013; 56: 1030-7
19. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-Analyses: the PRISMA statement. Ann Intern Med 2009; 151: 264-9, W64
20. Kluytmans JA, Overdevest IT, Willemsen I, et al. Extended-spectrum beta-lactamase-producing Escherichia coli from retail chicken meat and humans: comparison of strains, plasmids, resistance genes, and virulence factors. Clin Infect Dis 2013; 56: 478-87
21. Overdevest I, Willemsen I, Rijnsburger M, et al. Extended-spectrum β-lactamase genes of Escherichia coli in chicken meat and humans, the Netherlands. Emerg Infect Dis 2011; 17: 1216-22
22. Cortés P, Blanc V, Mora A, et al. Isolation and characterization of potentially pathogenic antimicrobial-resistant Escherichia coli strains from chicken and pig farms in Spain. Appl Environ Microbiol 2010; 76: 2799-805
23. Mora A, Herrera A, Mamani R, et al. Recent emergence of clonal group O25b: K1: H4-B2-ST131 ibeA strains among Escherichia coli poultry isolates, including CTX-M-9-producing strains, and comparison with clinical human isolates. Appl Environ Microbiol 2010; 76: 6991-7
24. Johnson JR, Sannes MR, Croy C, et al. Antimicrobial drug-resistant Escherichia coli from humans and poultry products, Minnesota and Wisconsin, 2002-2004. Emerg Infect Dis 2007; 13: 838-46
25. Borjesson S, Jernberg C, Brolund A, et al. Characterization of plasmidmediated AmpC-producing E. coli from Swedish broilers and association with human clinical isolates. Clin Microbiol Infect 2013; 19: E309-11
26. Doi Y, Paterson DL, Egea P, et al. Extended-spectrum and CMY-Type beta-lactamase-producing Escherichia coli in clinical samples and retail meat from Pittsburgh, USA and Seville, Spain. Clin Microbiol Infect 2010; 16: 33-8
27. Lspez-Cerero L, Egea P, Serrano L, et al. Characterisation of clinical and food animal Escherichia coli isolates producing CTX-M-15 extendedspectrum β-lactamase belonging to ST410 phylogroup A. Int J Antimicrob Agents 2011; 37: 365-7
28. Mulvey MR, Susky E, McCracken M, Morck DW, Read RR. Similar cefoxitin-resistance plasmids circulating in Escherichia coli from human and animal sources. Vet Microbiol 2009; 134: 279-87
29. Smet A, Martel A, Persoons D, et al. Comparative analysis of extendedspectrum-{beta}-lactamase-carrying plasmids from different members of Enterobacteriaceae isolated from poultry, pigs and humans: evidence for a shared {beta}-lactam resistance gene pool? J Antimicrob Chemother 2009; 63: 1286-8
30. Stokes MO, Cottell JL, Piddock LJ, et al. Detection and characterization of pCT-like plasmid vectors for blaCTX-M-14 in Escherichia coli isolates from humans, turkeys and cattle in England and Wales. J Antimicrob Chemother 2012; 67: 1639-44
31. Winokur P, Vonstein D, Hoffman L, Uhlenhopp E, Doern G. Evidence for transfer of CMY-2 AmpC β-lactamase plasmids between Escherichia coli and Salmonella isolates from food animals and humans. Antimicrob Agents Chemother 2001; 45: 2716-22
32. Yan JJ, Hong CY, Ko WC, et al. Dissemination of blaCMY-2 among Escherichia coli isolates from food animals, retail ground meats, and humans in southern Taiwan. Antimicrob Agents Chemother 2004; 48: 1353-6
33. Dhanji H, Murphy NM, Doumith M, et al. Cephalosporin resistance mechanisms in Escherichia coli isolated from raw chicken imported into the UK. J Antimicrob Chemother 2010; 65: 2534-7
34. Johnson JR, Nicolas-Chanoine MH, DebRoy C, et al. Comparison of Escherichia coli ST131 pulsotypes, by epidemiologic traits, 1967-2009. Emerg Infect Dis 2012; 18: 598-607
35. Toth A, Juhasz-Kaszanyitzky E, Mag T, Hajbel-Vekony G, Paszti J, Damjanova I. Characterization of extended-spectrum beta-lactamase (ESBL) producing Escherichia coli strains isolated from animal and human clinical samples in Hungary in 2006-2007. Acta Microbiol Immunol Hung 2013; 60: 175-85
36. Hu YY, Cai JC, ZhouHW, et al. Molecular typing of CTX-M-producing Escherichia coli isolates from environmental water, swine feces, specimens from healthy humans, and human patients. Appl Environ Microbiol 2013; 79: 5988-96
37. Kawamura K, Goto K, Nakane K, Arakawa Y. Molecular epidemiology of extended-spectrum beta-lactamases and Escherichia coli isolated from retail foods including chicken meat in Japan. Foodborne Pathog Dis 2014; 11: 104-10
38. Sabaté M, Prats G, Moreno E, Ballesté E, Blanch AR, Andreu A. Virulence and antimicrobial resistance profiles among Escherichia coli strains isolated from human and animal wastewater. Res Microbiol 2008; 159: 288-93
39. Tian G-B, Wang H-N, Zhang A-Y, et al. Detection of clinically important β-lactamases in commensal Escherichia coli of human and swine origin in western China. J Med Microbiol 2012; 61: 233-8
40. Wu G, Day MJ, Mafura MT, et al. Comparative analysis of ESBLpositive Escherichia coli isolates from animals and humans from the UK, the Netherlands and Germany. PLoS One 2013; 8: e75392
41. Accogli M, Fortini D, GiufreM, et al. IncI1 plasmids associated with the spread of CMY-2, CTX-M-1 and SHV-12 in Escherichia coli of animal and human origin. Clin Microbiol Infect 2013; 19: E238-40
42. Wang J, Stephan R, Karczmarczyk M, Yan Q, Hachler H, Fanning S. Molecular characterization of bla ESBL-harboring conjugative plasmids identified in multi-drug resistant Escherichia coli isolated from foodproducing animals and healthy humans. Front Microbiol 2013; 4: 188
43. Leistner R, Meyer E, Gastmeier P, et al. Risk factors associated with the community-Acquired colonization of extended-spectrum beta-lactamase (ESBL) positive Escherichia coli. An exploratory case-control study. PLoS ONE, 2013; 8: e74323
44. Manges AR, Smith SP, Lau BJ, et al. Retail meat consumption and the acquisition of antimicrobial resistant Escherichia coli causing urinary tract infections: a case-control study. Foodborne Pathog Dis 2007; 4: 419-31
45. Nicolas-Chanoine MH, Robert J, Vigan M, et al. Different factors associated with CTX-M-producing ST131 and non-ST131 Escherichia coli clinical isolates. PLoS ONE 2013; 8: e72191
46. Mataseje LF, Baudry PJ, Zhanel GG, et al. Comparison of CMY-2 plasmids isolated from human, animal, and environmental Escherichia coli and Salmonella spp. from Canada. Diagn Microbiol Infect Dis 2010; 67: 387-91
47. Bergeron CR, Prussing C, Boerlin P, et al. Chicken as reservoir for extraintestinal pathogenic Escherichia coli in humans, Canada. Emerg Infect Dis 2012; 18: 415-21
48. Bortolaia V, Larsen J, Damborg P, Guardabassi L. Potential pathogenicity and host range of extended-spectrum beta-lactamase-producing Escherichia coli isolates from healthy poultry. Appl Environ Microbiol 2011; 77: 5830-3
49. Giufre M, Graziani C, Accogli M, Luzzi I, Busani L, Cerquetti M. Escherichia coli of human and avian origin: detection of clonal groups associated with fluoroquinolone and multidrug resistance in Italy. J Antimicrob Chemother 2012; 67: 860-7
50. Oteo J, Diestra K, Juan C, et al. Extended-spectrum beta-lactamaseproducing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2. Int J Antimicrob Agents 2009; 34: 173-6
51. Johnson TJ, Kariyawasam S, Wannemuehler Y, et al. The genome sequence of avian pathogenic Escherichia coli strain O1: K1: H7 shares strong similarities with human extraintestinal pathogenic E. coli genomes. J Bacteriol 2007; 189: 3228-36
52. Johnson TJ, Wannemuehler Y, Johnson SJ, et al. Comparison of extraintestinal pathogenic Escherichia coli strains from human and avian sources reveals a mixed subset representing potential zoonotic pathogens. Appl Environ Microbiol 2008; 74: 7043-50
53. Bielak E, Bergenholtz RD, Jorgensen MS, Sorensen SJ, Hansen LH, Hasman H. Investigation of diversity of plasmids carrying the bla-TEM-52 gene. J Antimicrob Chemother 2011; 66: 2465-74
54. Ho PL, Lo WU, Yeung MK, et al. Dissemination of pHK01-like incompatibility group IncFII plasmids encoding CTX-M-14 in Escherichia coli from human and animal sources. Vet Microbiol 2012; 158: 172-9
55. Madec J-Y, Poirel L, Saras E, et al. Non-ST131 Escherichia coli from cattle harbouring human-like blaCTX-M-15-carrying plasmids. J Antimicrob Chemother 2012; 67: 578-81
56. Rodrigues C, Machado E, Peixe L, Novais A. IncI1/ST3 and IncN/ST1 plasmids drive the spread of blaTEM-52 and blaCTX-M-1/-32 in diverse Escherichia coli clones from different piggeries. J Antimicrob Chemother 2013; 68: 2245-8
57. Xia LN, Tao XQ, Shen JZ, et al. A survey of beta-lactamase and 16S rRNA methylase genes among fluoroquinolone-resistant Escherichia coli isolates and their horizontal transmission in Shandong, China. Foodborne Pathog Dis 2011; 8: 1241-8
58. Moodley A, Guardabassi L. Transmission of IncN plasmids carrying blaCTX-M-1 between commensal Escherichia coli in pigs and farm workers. Antimicrob Agents Chemother 2009; 53: 1709-11
59. Wu TL, Chia JH, Su LH, et al. CMY-2 beta-lactamase-carrying community-Acquired urinary tract Escherichia coli: genetic correlation with Salmonella enterica serotypes Choleraesuis and Typhimurium. Int J Antimicrob Agents 2007; 29: 410-6
60. van Belkum A, Tassios PT, Dijkshoorn L, et al. Guidelines for the validation and application of typing methods for use in bacterial epidemiology. Clin Microbiol Infect 2007; 13 Suppl 3: 1-46
61. Reuter S, Ellington MJ, Cartwright EJ, et al. Rapid bacterial whole-genome sequencing to enhance diagnostic and public health microbiology. JAMA Intern Med 2013; 173: 1397-404
62. Snitkin ES, Zelazny AM, Thomas PJ, et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med 2012; 4: 148ra16
63. Hunter PA, Dawson S, French GL, et al. Antimicrobial-resistant pathogens in animals and man: prescribing, practices and policies. J Antimicrob Chemother 2010; 65: i3-17
64. Platteel TN, Leverstein-Van Hall MA, Cohen Stuart JW, et al. Differences in the antibiotic susceptibility of human Escherichia coli with poultryassociated and non-poultry-Associated extended-spectrum betalactamases. Eur J Clin Microbiol Infect Dis 2013; 32: 1091-5
65. Carattoli A, Garcia-Fernandez A, Varesi P, et al. Molecular epidemiology of Escherichia coli producing extended-spectrum beta-lactamases isolated in Rome, Italy. J Clin Microbiol 2008; 46: 103-8
66. Hopkins KL, Liebana E, Villa L, Batchelor M, Threlfall EJ, Carattoli A. Replicon typing of plasmids carrying CTX-M or CMY beta-lactamases circulating among Salmonella and Escherichia coli isolates. Antimicrob Agents Chemother 2006; 50: 3203-6
67. Villa L, Garcia-Fernandez A, Fortini D, Carattoli A. Replicon sequence typing of IncF plasmids carrying virulence and resistance determinants. J Antimicrob Chemother 2010; 65: 2518-29
68. Machado E, Coque TM, Canton R, et al. High diversity of extendedspectrum beta-lactamases among clinical isolates of Enterobacteriaceae from Portugal. J Antimicrob Chemother 2007; 60: 1370-4
69. Mulvey MR, Bryce E, Boyd DA, et al. Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals. Antimicrob Agents Chemother 2005; 49: 358-65
70. Woodford N, Ward ME, Kaufmann ME, et al. Community and hospital spread of Escherichia coli producing CTX-M extendedspectrum beta-lactamases in the UK. J Antimicrob Chemother 2004; 54: 735-43
71. Tarrant F, MacGowan AP, Walsh TR. Occurrence and current frequency of CTX-M-Type beta-lactamases from a regional hospital in the South West of England. J Antimicrob Chemother 2007; 59: 815-6
72. Matsumura Y, Yamamoto M, Nagao M, et al. Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-beta-lactamase-producing Escherichia coli in Japan. J Antimicrob Chemother 2012; 67: 2612-20
73. Suzuki S, Shibata N, Yamane K, Wachino J, Ito K, Arakawa Y. Change in the prevalence of extended-spectrum-beta-lactamase-producing Escherichia coli in Japan by clonal spread. J Antimicrob Chemother 2009; 63: 72-9